Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-book ratio

Percentile
P100
Near historical high
vs 2Y Ago
2.9x
Strong expansion
Streak
5 yr
Consecutive growthElevated
PeriodValueYoY Change
20253.80+21.5%
20243.12+142.1%
20231.29+170.8%
2022-1.82+54.5%
2021-4.01+83.1%
2020-23.74-